Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8 + T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research(2019)
摘要
These results highlight a critical role of OX40 activation in potentiating the effector function of tumor-reactive CD8 T cells and suggest further evaluation of OX40 agonist-based combinations in patients with immune-resistant tumors.
更多查看译文
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要